COMMUNIQUÉ DE PRESSE publié le 25/03/2026 à 13:20, il y a 2 mois 1 jour Lobe Sciences Ltd. Reports Improved Financial Position and Strategic Update Lobe Sciences Ltd. significantly improves financial position: liabilities down 81%, cash up 24x, net working capital up $6.1M, outstanding warrants down 70%, and strengthened the balance sheet and capital structure Financial Position Balance Sheet Capital Structure Strategic Update Lobe Sciences Ltd.
BRÈVE publiée le 09/03/2026 à 05:05, il y a 2 mois 18 jours Lobe Sciences nomme Mirza Rahimani au poste de directeur financier Gouvernance D'Entreprise Biopharmaceutique Sciences Du Lobe Responsable Financier Mirza Rahimani
BRÈVE publiée le 09/03/2026 à 05:05, il y a 2 mois 18 jours Lobe Sciences Appoints Mirza Rahimani as CFO Corporate Governance Biopharmaceutical Financial Officer Lobe Sciences Mirza Rahimani
COMMUNIQUÉ DE PRESSE publié le 09/03/2026 à 05:00, il y a 2 mois 18 jours Lobe Sciences Announces Appointment of Mr. Mirza Rahimani, CPA, CA as Chief Financial Officer Lobe Sciences Ltd. appoints Mirza Rahimani as Chief Financial Officer, leveraging his extensive finance experience. Learn more about the company's strategic developments and goals Chief Financial Officer Strategic Development Finance Lobe Sciences Ltd. Mirza Rahimani
BRÈVE publiée le 05/03/2026 à 13:45, il y a 2 mois 21 jours Lobe Sciences Ltd. annonce sa participation aux conférences sur les soins de santé à Miami Conférences Biopharmaceutique Soins De Santé Miami Programmes Thérapeutiques
BRÈVE publiée le 05/03/2026 à 13:45, il y a 2 mois 21 jours Lobe Sciences Ltd. Announces Participation at Miami Healthcare Conferences Healthcare Conférences Biopharmaceutical Miami Therapeutic Programs
COMMUNIQUÉ DE PRESSE publié le 05/03/2026 à 13:40, il y a 2 mois 21 jours Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences Lobe Sciences announces CEO availability for meetings during Jefferies and Leerink Healthcare Conferences in Miami. Company focuses on advancing therapeutic programs for medical needs Lobe Sciences Jefferies Conference Therapeutic Programs CEO Availability Leerink Healthcare Conference
BRÈVE publiée le 03/02/2026 à 13:05, il y a 3 mois 23 jours Lobe Sciences publie ses résultats financiers et ses initiatives pour le premier trimestre 2026 Investissement En R&D Développement De Médicaments Résumé Financier Sciences Du Lobe Résultats Du T1 2026
BRÈVE publiée le 03/02/2026 à 13:05, il y a 3 mois 23 jours Lobe Sciences Reports Q1 2026 Financial Results and Initiatives Drug Development R&D Investment Financial Summary Lobe Sciences Q1 2026 Results
COMMUNIQUÉ DE PRESSE publié le 03/02/2026 à 13:00, il y a 3 mois 23 jours Lobe Sciences Reports First Quarter 2026 Results and Highlights Lobe Sciences Ltd. reports unaudited financial results for Q1:2026, with increased R&D activities and improved operating efficiency. The Company advances development programs in diseases with unmet medical needs Financial Results R&D Activities Operating Efficiency Medical Needs Lobe Sciences Ltd.
Publié le 26/05/2026 à 18:39, il y a 12 heures 51 minutes Déclaration des opérations d'achats d'actions réalisées le 18 mai 2026
Publié le 26/05/2026 à 18:39, il y a 12 heures 51 minutes Reporting on share buyback transactions carried out on May 18, 2026
Publié le 26/05/2026 à 17:45, il y a 13 heures 46 minutes EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS
Publié le 26/05/2026 à 17:45, il y a 13 heures 46 minutes EURAZEO INVESTIT DANS BABYLON, SPÉCIALISTE FRANÇAIS DES APARTHOTELS DE NOUVELLE GÉNÉRATION
Publié le 26/05/2026 à 17:40, il y a 13 heures 51 minutes LDC : Nombre total de droits de vote et d'actions composant le capital au 30.04.26.
Publié le 27/05/2026 à 02:10, il y a 5 heures 21 minutes Western Investment Company Reports First Quarter 2026 Results and Announces Executive Personnel Changes
Publié le 27/05/2026 à 01:45, il y a 5 heures 46 minutes Organto Foods Announces Record First Quarter 2026 Financial Results
Publié le 27/05/2026 à 00:25, il y a 7 heures 6 minutes Revolve Reports Q3 F2026 Results Backed by Strong Progress Across North American Portfolio
Publié le 26/05/2026 à 22:15, il y a 9 heures 16 minutes LaFleur Announces Bought Deal Equity Offerings for Gross Proceeds of C$8 Million
Publié le 26/05/2026 à 22:01, il y a 9 heures 30 minutes Kidoz Inc. Reports Q1 2026 Financial Results with YoY Revenue Growth, Accelerating Strategic Investment in AI
Publié le 27/05/2026 à 07:29, il y a 2 minutes Aroundtown announces Q1 2026 results in line with guidance. Earnings profile reinforced by successful GCP share-to-share offer and effective capital recycling
Publié le 27/05/2026 à 07:05, il y a 25 minutes USI Showcases Advanced SiC Chip-Embedded Packaging Technology at PCIM Europe 2026
Publié le 27/05/2026 à 07:00, il y a 31 minutes Swiss Life publie le compte d’exploitation 2025 relatif aux affaires LPP
Publié le 27/05/2026 à 06:00, il y a 1 heure 31 minutes Verve Group Reports Solid Organic Growth in the First Quarter, Along with Strong Operating Performance and Significant Cash Flow Growth
Publié le 26/05/2026 à 18:50, il y a 12 heures 40 minutes The AI Gold Rush Is Running Into a Margin Problem